DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses

Abstract

Radiotherapy resistance is one of the major factors limiting the efficacy of radiotherapy in lung cancer patients. The extensive investigations indicate the diversity in the mechanisms underlying radioresistance. Here, we revealed that DNA damage binding protein 2 (DDB2) is a potential regulator in the radiosensitivity of non-small cell lung cancer (NSCLC… (More)
DOI: 10.1007/s13277-016-5203-y

Topics

5 Figures and Tables

Cite this paper

@article{Zou2016DDB2IR, title={DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses}, author={Ning Zou and Guozhen Xie and Tiantian Cui and Amit Kumar Srivastava and Meihua Qu and Linlin Yang and Shaozhong Wei and Yanfang Zheng and Qi-En Wang}, journal={Tumor Biology}, year={2016}, volume={37}, pages={14183-14191} }